The Medicines Company Infectious Disease Care Group Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
The Medicines Company Infectious Disease Care Group General Information
Description
Developer of medicinal products committed to fighting bacterial infections and resistant organisms. The company's medicines, which include trademarked products named Vabomere™, Orbactiv® and Minocin IV, focus on fighting urinary tract infections, gram-positive bacteria and other multidrug-resistant pathogens as identified by the United States Centers for Disease Control and Prevention and the World Health Organization.
Contact Information
Website
www.mdcoidc.comCorporate Office
- Parsippany, NJ
- United States
Corporate Office
- Parsippany, NJ
- United States
The Medicines Company Infectious Disease Care Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
The Medicines Company Infectious Disease Care Group Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
The Medicines Company Infectious Disease Care Group FAQs
-
Where is The Medicines Company Infectious Disease Care Group headquartered?
The Medicines Company Infectious Disease Care Group is headquartered in Parsippany, NJ.
-
What industry is The Medicines Company Infectious Disease Care Group in?
The Medicines Company Infectious Disease Care Group’s primary industry is Drug Discovery.
-
Is The Medicines Company Infectious Disease Care Group a private or public company?
The Medicines Company Infectious Disease Care Group is a Private company.
-
What is the current valuation of The Medicines Company Infectious Disease Care Group?
The current valuation of The Medicines Company Infectious Disease Care Group is .
-
What is The Medicines Company Infectious Disease Care Group’s current revenue?
The current revenue for The Medicines Company Infectious Disease Care Group is .
-
Who are The Medicines Company Infectious Disease Care Group’s investors?
The Medicines Company has invested in The Medicines Company Infectious Disease Care Group.
-
When was The Medicines Company Infectious Disease Care Group acquired?
The Medicines Company Infectious Disease Care Group was acquired on 05-Jan-2018.
-
Who acquired The Medicines Company Infectious Disease Care Group?
The Medicines Company Infectious Disease Care Group was acquired by Melinta Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
